Introduction
Bone morphogenetic proteins (BMPs) are a family of proteins originally identified a s inducers of bone and cartilage formation in ectopic sites in vivo [1, 2] . Subsequently, BMPs have been shown to regulate growth a n d differentiation of several cell types. T h e y stimulate matrix synthesis in chondroblasts, alkaline phosphatase activity and collagen synthesis in osteoblasts [3] , chemotaxis of monocytes [4] and differentiation of neural cells [5, 6] a n d play important roles in embryogenesis {reviewed by Hogan (1996) [ 71 }.
More than ten proteins are found to belong to the BMP family including BMP-2 to -6, osteogenic protein -1 and -2 (which are also referred to as BMP-7 and -8, respectively) and growth/ differentiation factor (GDF)-5 to -7.
T h e BMP family of proteins belongs to the transforming growth factor /j ( T G BMP-2/BMP-4 bind BMPR-IA and BMPR-IB with a similar affinity, which is in contrast to BMP-7 which has a higher affinity for BMPR-IB than for BMPR-IA. Furthermore, BMP-7, but not BMP-4, binds the activin receptor type I
In this study the role of BMP type I receptors in the initiation of osteogenic or chondrogenic development in mesenchymal progenitors C3HIOT; was investigated. Originally, this pluripotential murine progenitor line was established from an early-stage mouse embryo and has the ability to differentiate into different mesenchymal lineages [15, 16] . In C3HlOT; cells members of the BMP family are capable of mediating differentiation into chondrocytes, osteoblasts and adipocytes [ 17, 181 . A tetracycline-dependent conditional expression system for human BMPR-IA, @k3) was established in these C3HlOTi cells. In the absence of exogenously added ligand, expression of the recombinant in C3HlOT; progenitors was sufficient for the onset of osteolchondrogenic differentiation which was substantiated both histologically and genetically. The capacity of the Alk3-expressing C3HlOT; cells to undergo osteo-/chondrogenic development seemed primarily due to the fact that recombinant BMPR-I compensates for moderate levels of endogenous BMPR-I in these cells and thus leads to an enhanced sensitivity of this line towards endogenously produced BMP family members such as BMP-4 or GDF-5. The expression of the dominant negative BMPR-IA (Alk3A), however, inhibits osteo-/chondrogenic differentiation and also dramatically rearranges the morphology of the C3HlOT; progenitors. Low levels of BMP signalling resulting from autocrine BMP and BMPR seems, therefore, to be essential for ~141.
the maintenance of the fibroblastic morphology of C3HIOT; cells.
Materials and methods

Cell lines, culture conditions and transfection experiments
C3HlOT; progenitors were cultured as described [18] . Cells were plated at a density of 5000 cells/ cmz in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% foetal calf serum. After reaching confluence (arbitrarily termed day 0) 50 pglml ascorbic acid and 10 mM P-glycerophosphate were added as specified by Owen et al. [19] for the cultivation of native osteoblast-like cells. C3H 1 0 T i lines with the permanent expression of the tetracycline-sensitive transactivator (rtTA) were individually selected and maintained in 750 pg/mlG418. Alk.3 andAlk3A were cloned into pUHG16-3 [20] and were selected by co-transfection with pSV2pac which mediates resistance to puromycin (2.5 pg/ml) in rtTA-expressing C3HlOT; lines. Individual lines were checked for their induction kinetics with doxycycline (1 pg/ml).
Histological methods and verification of cellular phenotypes
Osteoblasts exhibit a stellate morphology displaying high levels of alkaline phosphatase activity which was visualized by cellular staining with a-naphthyl-phosphate and Fast Red. Osteogenesis was also investigated by reverse transcriptionpolymerase chain reaction (RT-PCR) analyses for genes typical or specific for the osteogenic developmental sequence namely collagen I, osteonectin and osteocalcin and parathyroid hormone (PTH) receptor (PTH/PTHrP-receptor). Chondrocytes were identified by staining with Alcian Blue at pH 2.5. The marker gene for chondrocytes was collagen 11.
RT-PCR
RNA was isolated from cells by the guanidinium isothiocyanate method. Total RNA (10 pg) was reverse transcribed after annealing with 2.5 ng of random hexamer primers (Gibco-BRL) and reverse transcriptase (Gibco-BRL) in 40 111. A 1 pl aliquot of the single-stranded cDNA sample was used in a 30 cycle PCR. The sequence of marker gene-specific primers as well as of the hypoxanthine-phosphoribosyl-transferase gene will be provided on request.
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Transcriptional activation of BMP-receptors by tetracyclines in mesenchymal progenitors C3HIOTi
A system for the conditional activation of genes in mammalian cells has recently been described [20] . Briefly, a transactivator (rtTA) consisting of a mutant tet-repressor which was fused to the transactivating domain of W 16 binds tet-operators (tet-response element; Figure lb) and activates transcription from a minimal promoter (in this case the cytomegalovirus promoter) in the presence of tetracycline derivatives (e.g., doxycycline or anhydrotetracycline). Establishment of such a system may lead to a control of transcriptional rates in the order of 103-104 [20] . We applied this system for the expression of BMPR-IA Clllk3) and its dominant-negative form Alk3A, respectively, in the mesenchymal progenitor cell line C3H101'; (Figure 1 ). After establishing and osteocalcin; the latter is highly specific for late stages of osteogenesis. Also, the rate of transcription of the chondrocyte specific collagen zl (11) gene is increased (Figure 3 ). So even in the absence of exogenously added ligand, C3H10T&Alk3 exhibits a clear onset of osteogenic as well as chondrogenic development on a histological and genetic basis. In contrast, if the dominant-negative form of fllk3, Alk3A, is expressed in the mesenchymal progenitors, expression of osteogenic or chondrogenic marker genes is suppressed in comparison with parental C3HlOTi cells (Figure 3 ). In addition, the cell morphology is dramatically rearranged and the fibroblastic appearance of the parental C3HlOT; cells is lost shortly after reaching confluence (>day 0). This indicates that a base level of BMP-signalling in C3H10T; cells might be essential for the morphological integrity of this cell type (Figure 2 ).
The deficiency in endogenous BMP type I receptors contributes t o the stable progenitor status of C3HIOTi cells
The C3H 10Ti mesenchymal progenitors exhibit a stable fibroblastic phenotype although it has been documented that these cells constitutively express a broad spectrum of TGFP superfamily members such as TGFPl-3, BMP-3, -4, -6 [21] . We confirmed this observation and show that these cells also constitutively synthesize a low level of GDF-5 mRNA (Figure 3b ). GDF-5 seems to interact predominantly with BMPR-IB ("llk6) [22] . Although these cells synthesize such a number of various endogenous ligands which are able to interact with BMPR-IA or -IB they seem to be unable to respond to these factors by undergoing mesenchymal differentiation. By semiquantitative RT-PCR analysis of BMP receptor transcripts in C3HlOT; cells we can show that these cells express BMPR-IA or -IB receptors are supplied recombinantly, the endogenous ligand production may be sufficient to form enough heteromeric complexes such that osteo-/chondrogenic development is initiated (Figures 2 and 3a) . Low BMP type I receptor densities may therefore contribute to the observed stable phenotype of C3H10Ti as mesenchy ma1 progenitors so that only the exogenous addition or recombinant expression of BMP may lead to substantial heteromeric receptor formation and the signalling needed for the onset of osteo-I chondrogenic development. Furthermore, it is an interesting feature that the fibroblastic nature of C3HlOT; cells is lost during cultivation when the dominant-negative Alk3A is expressed, indicating that BMP signalling even at modest levels has a physiological impact in this particular mesenchymal progenitor line. 
